We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Interbody Fusion Device Provides Integrated Fixation

By HospiMedica International staff writers
Posted on 24 Jun 2018
Print article
Image: Multiple views of the ENZA-A Titanium ALIF system (Photo courtesy of Camber Spine).
Image: Multiple views of the ENZA-A Titanium ALIF system (Photo courtesy of Camber Spine).
A minimally invasive anterior lumbar interbody fusion (ALIF) system uses autogenous bone grafts to stabilize patients with degenerative disc disease (DDD).

The Camber Spine (Wayne, PA, USA) ENZA-A Titanium ALIF system consists of a three-dimensional (3D) printed titanium body with multiple openings to allow a large volume of autogenous bone graft to be easily packed into the implant, and roughened cranial and caudal surfaces that encourage bone growth onto the surface of the device. The surfaces are deliberately designed with pores that average 500 microns in diameter, the optimal environment for bone growth that fully incorporates the implant with the vertebral bodies.

The ENZA-A features two sharpened anchor plates housed within the 3D-printed body until they are deployed into the adjacent vertebrae for fixation. Surgery time is reduced thanks to the single, inline instrumentation used to insert the device, deploy the anchor plates, and lock it in place. Patient safety is increased by minimizing the size of the incision and retraction required for implantation. The ENZA-A has been approved by the U.S. Food and Drug Administration (FDA) for use at one or two contiguous levels from L2 to S1 using supplementary fixation systems.

“With ergonomic instrumentation, this system is easy to use and makes implantation more streamlined,” said Seth Anderson, executive VP of new business development and surgeon relations at Camber Spine. “The ENZA-A is the second device in the ENZA-line of implants; this interbody, coupled with additional product launches expected later this year in the cervical and lateral markets, will continue to grow Camber Spine's presence as a market leader and innovator in minimally invasive spine surgery technology advancements.”

Interbody devices are designed to replace the intervertebral disc of the spine, enhancing stability in the region while the spine fuses. Over time, the packed bone graft material is gradually replaced by natural bone forming a solid piece. Fusion procedures typically use a posterior fixation device to the associated level, since the surgeons will implant interbody devices from an anterior approach and flip the patient over to implant a posterior pedicle screw device. This combination increases fusion success.

Related Links:
Camber Spine

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.